First International Consensus Conference on lesions of uncertain malignant potential in the breast (B3 lesions) Christoph J. RagethElizabeth AM O’FlynnZsuzsanna Varga Review Open access 13 August 2016 Pages: 203 - 213
Prognostic significance of androgen receptor expression in invasive breast cancer: transcriptomic and protein expression analysis Mohammad A. AleskandaranyRezvan AbduljabbarEmad A. Rakha Preclinical study 11 August 2016 Pages: 215 - 227
Breast sarcomas and malignant phyllodes tumours: comparison of clinicopathological features, treatment strategies, prognostic factors and outcomes Sue Zann LimSathiyamoorthy SelvarajanPuay Hoon Tan Preclinical study 19 August 2016 Pages: 229 - 244
Implementation of next-generation sequencing for molecular diagnosis of hereditary breast and ovarian cancer highlights its genetic heterogeneity Pedro PintoPaula PauloManuel R. Teixeira Preclinical study 23 August 2016 Pages: 245 - 256
St Gallen 2015 subtyping of luminal breast cancers: impact of different Ki67-based proliferation assessment methods Cornelia M. FockePaul J. van DiestThomas Decker Preclinical study 24 August 2016 Pages: 257 - 263
Clinical significance of noncalcified lung nodules in patients with breast cancer Feng LiSamuel G. ArmatoHeber MacMahon Clinical trial 09 August 2016 Pages: 265 - 271
Impact of clinical trial on survival outcomes Fanny Le DuTakeo FujiiNaoto T. Ueno Clinical trial 16 August 2016 Pages: 273 - 281
Effects of a multicomponent physical activity behavior change intervention on breast cancer survivor health status outcomes in a randomized controlled trial Laura Q. RogersKerry S. CourneyaEdward McAuley Clinical trial 18 August 2016 Pages: 283 - 291
Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study Antonis ValachisHans GarmoLars Holmberg Epidemiology Open access 05 August 2016 Pages: 293 - 303
Cumulative risk of false positive test in relation to breast symptoms in mammography screening: a historical prospective cohort study Deependra SinghJanne PitkäniemiAhti Anttila Epidemiology Open access 05 August 2016 Pages: 305 - 313
21-Gene recurrence score decreases receipt of chemotherapy in ER+ early-stage breast cancer: an analysis of the NCDB 2010–2013 Benjamin M. ParsonsJeffrey LandercasperLeah L. Dietrich Epidemiology Open access 09 August 2016 Pages: 315 - 326
Long-term chemotherapy-induced peripheral neuropathy among breast cancer survivors: prevalence, risk factors, and fall risk Ting BaoCoby BasalJun J. Mao Epidemiology 10 August 2016 Pages: 327 - 333
Lifetime grain consumption and breast cancer risk Maryam S. FarvidEunyoung ChoWalter C. Willett Epidemiology 10 August 2016 Pages: 335 - 345
Vigorous physical activity and risk of breast cancer in the African American breast cancer epidemiology and risk consortium Zhihong GongChi-Chen HongLynn Rosenberg Epidemiology 11 August 2016 Pages: 347 - 356
Adjuvant systemic therapy in early breast cancer: impact of guideline changes and clinicopathological factors associated with nonadherence at a nation-wide level A. M. F. VerschoorA. KuijerS. G. Elias Epidemiology 12 August 2016 Pages: 357 - 365
Clinicopathological and surgical factors associated with long-term survival in patients with HER2-positive metastatic breast cancer K. HaranoX. LeiM. Chavez-MacGregor Epidemiology 13 August 2016 Pages: 367 - 374
Resting heart rate as a prognostic factor for mortality in patients with breast cancer Dong Hoon LeeSeho ParkJustin Y. Jeon Epidemiology 20 August 2016 Pages: 375 - 384
Reevaluation of RINT1 as a breast cancer predisposition gene Na LiElla R. ThompsonIan G. Campbell Brief Report 20 August 2016 Pages: 385 - 392
Erratum to: The effect of trastuzumab-based chemotherapy in small node-negative HER2-positive breast cancer Mette S. van RamshorstMargriet van der Heiden-van der LooGabe S. Sonke Erratum 17 August 2016 Pages: 393 - 393